{'fraction_non_alphanumeric': 0.027412280701754384, 'fraction_numerical': 0.02631578947368421, 'mean_word_length': 5.615942028985507, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Proceedings: Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined immunodeficiency disease.

Abstract Transfer factor was administered to a 10-month-old infant with severe combined immunodeficiency disease in an attempt to stimulate cell-mediated immunity. No change in thymus-dependent lymphocyte function was observed. However, three weeks after transfer factor there was a marked increase in the leukocyte count, with the appearance of mature plasma cells in the peripheral blood and bone marrow. The serum IgM rose to 2000 mg per 100 ml; several blood-group antibodies, including anti-i, became detectable. Although the relation of transfer factor to the polyclonal gammopathy may be coincidental, the administration of transfer factor to patients with severe combined immunodeficiency disease may induce uncontrolled B-cell proliferation. (N Engl J Med 289:1385–1389, 1973)